Clinical Trials Logo
  1. Home
  2. Diabetes Mellitus, Type 2
  3. NCT01943214
  4. Details
NCT01943214 Clinical Trial

Prospective Cohort Study of the Body Constitution Among Type II Diabetes Mellitus Patients

Diabetes Mellitus Clinical Trial

Official title:
Prospective Cohort Study of the Body Constitution Among Type II Diabetes Mellitus Patients

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT01943214
Other study ID # CE13177
Secondary ID
Status Recruiting
Phase N/A
First received September 11, 2013
Last updated September 16, 2013
Start date July 2013
Est. completion date December 2016

Study information
Verified date September 2013
Source Taichung Veterans General Hospital
Contact n/a
Is FDA regulated No
Health authority Taiwan : Food and Drug Administration
Study type Observational [Patient Registry]

Clinical Trial Summary

By analyzing the relationship between the body constitution and the progression of Type II diabetes mellitus, its morbidities, mortality and the impact of the life quality, we try to provide an useful tool, body constitution, to stratify the patients accordingly for individualized health care.

Description:

The study participants are recruited from the Diabetes Shared Care Network of the Taichung Veterans General Hospital (Taichung, Taiwan)

Recruitment information / eligibility
Status Recruiting
Enrollment 1000
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 75 Years
Eligibility Inclusion Criteria:

- patient diagnosed as Type II diabetes mellitus by Endocrinology specialist.

- aged from 20 to 75 years old.

- clear conscious, willing to join the program.

Exclusion Criteria:

- Severe mental illness, which lead to unable to fulfill the questionaire

- Major surgical intervention,medical events (such as acute myocardial infarction, cerebral vascular accident...et al.,), chemotherapy or radiation therapy within past one month , which made body constitution measurement unavailable.

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Taiwan Taichung Veterans General Hospital Taichung

Sponsors (1)
Lead Sponsor Collaborator
Taichung Veterans General Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome
Type Measure Description Time frame Safety issue
Primary Body constitution of type II diabetes mellitus patients Two years follow up after being recruited No
Secondary All cause mortality of type II diabetes mellitus patients Two years follow up after being recruited No
Secondary Life quality of diabetes mellitus patients Two years follow up after being recruited No
Secondary Diabetic retinopathy of type II diabetes mellitus patients Two years follow up after being recruited No
Secondary Diabetic nephropathy of type II diabetes mellitus patients Two years follow up after being recruited No
Secondary Diabetic neuropathy of type II diabetes mellitus patients Two years follow up after being recruited No
See also
  Status Clinical Trial Phase
Completed NCT03743779 - Mastering Diabetes Pilot Study
Completed NCT03786978 - Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus N/A
Completed NCT01804803 - DIgital Assisted MONitoring for DiabeteS - I N/A
Completed NCT05039970 - A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT04068272 - Safety of Bosentan in Type II Diabetic Patients Phase 1
Completed NCT03243383 - Readmission Prevention Pilot Trial in Diabetes Patients N/A
Completed NCT03730480 - User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS) N/A
Recruiting NCT02690467 - Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm. N/A
Completed NCT02229383 - Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus Phase 3
Completed NCT06181721 - Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT04489043 - Exercise, Prediabetes and Diabetes After Renal Transplantation. N/A
Withdrawn NCT03319784 - Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients Phase 4
Completed NCT03542084 - Endocrinology Auto-Triggered e-Consults N/A
Completed NCT02229396 - Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo Phase 3
Recruiting NCT05544266 - Rare and Atypical Diabetes Network
Completed NCT01892319 - An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
Completed NCT05031000 - Blood Glucose Monitoring Systems: Discounter Versus Brand N/A
Recruiting NCT04039763 - RT-CGM in Young Adults at Risk of DKA N/A